Selective increase in the extracellular d-serine contents by d-cycloserine in the rat medial frontal cortex

Neurochemistry International

Volumn 51, Issue 2-4 SPEC. ISS., 2007, Pages 233-236

  Fujihira, Takahisa ^a   Kanematsu, Sotaro ^a   Umino, Asami ^a   Yamamoto, Naoki ^a   Nishikawa, Toru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

d Cycloserine; d Serine; Glycine; In vivo microdialysis; l Serine; Medial frontal cortex

Indexed keywords

ALANINE; ASPARAGINE; ASPARTIC ACID; CYCLOSERINE; DEXTRO SERINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SERINE; TAURINE; THREONINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIALYSIS; FRONTAL CORTEX; IN VIVO STUDY; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIPSYCHOTIC AGENTS; CYCLOSERINE; EXCITATORY AMINO ACID AGONISTS; EXTRACELLULAR FLUID; FRONTAL LOBE; GLUTAMIC ACID; INFUSIONS, PARENTERAL; MALE; MICRODIALYSIS; PSYCHOTIC DISORDERS; RATS; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; SERINE; STEREOISOMERISM; SYNAPTIC TRANSMISSION; UP-REGULATION;

RATTUS;

EID: 34547467734     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.06.003     Document Type: Article

References (26)

1. Baran H., Gramer M., and Loscher W. Alterations in plasma and brain amino acids after administration of the glycine/NMDA receptor partial agonist, d-cycloserine, to mice and rats. Eur. J. Pharmacol. 273 (1995) 197-201
2. Butterfield D.A., and Pocernich C.B. The glutamatergic system and Alzheimer's disease: therapeutic implications. CNS Drugs 17 (2003) 641-652
3. Chen Z., Kennedy D.J., Wake K.A., Zhuang L., Ganapathy V., and Thwaites D.T. Structure, tissue expression pattern, and function of the amino acid transporter rat PAT2. Biochem. Biophys. Res. Commun. 304 (2003) 747-754
4. Coyle J.T., Tsai G., and Goff D.C. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr. Drug Targets CNS Neurol. Disord. 1 (2002) 183-189
5. Danysz W., and Parsons A.C. Glycine and N-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev. 50 (1998) 597-664
6. Davis M., Ressler K., Rothbaum B.O., and Richardson R. Effects of d-cycloserine on extinction: translation from preclinical to clinical work. Biol. Psychiat. 60 (2006) 369-375
7. Dunlop D.S., and Neidle A. Regulation of serine racemase activity by amino acids. Brain Res. Mol. Brain Res. 133 (2005) 208-214
8. Frecking M.G., and Hoeprich P.D. Effect of cycloserines on d-amino acid oxidase. Arch. Biochem. Biophys. 115 (1966) 108-111
9. Guastella A.J., Dadds M.R., Lovibond P.F., Mitchell P., and Richardson R. A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear. J. Psychiat. Res. 41 (2007) 466-471
10. Hashimoto A., Nishikawa T., Konno R., Niwa A., Yasumura Y., Oka T., and Takahashi K. Free d-serine, d-aspartate and d-alanine in central nervous system and serum in mutant mice lacking d-amino acid oxidase. Neurosci. Lett. 152 (1993) 33-36
11. Hashimoto A., Oka T., and Nishikawa T. Extracellular concentration of endogenous free d-serine in the rat brain as revealed by in vivo dialysis. Neuroscience 66 (1995) 635-643
12. Heifets L.B. Antimycobacterial drugs. Semin. Respir. Infect. 9 (1994) 84-103
13. Heresco-Levy U., Kremer I., Javitt D.C., Goichman R., Reshef A., Blanaru M., and Cohen T. Pilot-controlled trial of d-cycloserine for the treatment of post-traumatic stress disorder. Int. J. Neuropsychopharmacol. 5 (2002) 301-307
14. Hjörth S., and Sharp T. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 48 (1991) 1779-1786
15. Hofmann S.G., Meuret A.E., Smits J.A., Simon N.M., Pollack M.H., Eisenmenger K., Shiekh M., and Otto M.W. Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Arch. Gen. Psychiat. 63 (2006) 298-304
16. Javitt D.C. Glutamate as a therapeutic target in psychiatric disorders. Mol. Psychiat. 9 984-997 (2004) 979
17. Matthews J.N.S., Altman D.G., Campbell M.J., and Royston P. Analysis of serial measurements in medical research. Br. Med. J. 300 (1990) 230-235
18. Metzner L., Kottra G., Neubert K., Daniel H., and Brandsch M. Serotonin, l-tryptophan, and tryptamine are effective inhibitors of the amino acid transport system PAT1. FASEB J. 19 (2005) 1468-1473
19. Nishijima K., Kashiwa A., Hashimoto A., Iwama H., Umino A., and Nishikawa T. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat medial frontal cortex and striatum as revealed by in vivo dialysis. Synapse 22 (1996) 304-312
20. Nishikawa T. Metabolism and functional roles of endogenous d-serine in mammalian brains. Biol. Pharm. Bull. 28 (2005) 1561-1565
21. Ogawa M., Shigeto H., Yamamoto T., Oya Y., Wada K., Nishikawa T., and Kawai M. d-Cycloserine for the treatment of ataxia in spinocerebellar degeneration. J. Neurol. Sci. 210 (2003) 53-56
22. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 5th ed. (2005), Elsevier Academic Press, Amsterdam
23. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., Hodges L., and Davis M. Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch. Gen. Psychiat. 61 (2004) 1136-1144
24. Ribeiro C.S., Reis M., Panizzutti R., de Miranda J., and Wolosker H. Glial transport of the neuromodulator d-serine. Brain Res. 929 (2002) 202-209
25. Tanii Y., Nishikawa T., Umino A., and Takahashi K. Phencyclidine increases extracellular dopamine metabolites in rat medial frontal cortex as measured by in vivo dialysis. Neurosci. Lett. 112 (1990) 318-323
26. Wolosker H., Panizzutti R., and de Miranda J. Neurobiology through the looking-glass: d-serine as a new glial-derived transmitter. Neurochem. Int. 41 (2002) 327-332